IGF-1 from adipose-derived mesenchymal stem cells promotes radioresistance of breast cancer cells

Asian Pac J Cancer Prev. 2014;15(23):10115-9. doi: 10.7314/apjcp.2014.15.23.10115.

Abstract

Purpose: The aim of this study was to investigate effects of adipose-derived mesenchymal stem cells (AMSCs) on radioresistance of breast cancer cells.

Materials and methods: MTT assays were used to detect any influence of AMSC supernatants on proliferation of breast cancer cells; cell migration assays were used to determine the effect of breast cancer cells on the recruitment of AMSCs; the cell survival fraction post-irradiation was assessed by clonogenic survival assay; γ-H2AX foci number post-irradiation was determined via fluorescence microscopy; and expression of IGF-1R was detected by Western blotting.

Results: AMSC supernatants promoted proliferation and radioresistance of breast cancer cells. Breast cancer cells could recruit AMSCs, especially after irradiation. IGF-1 derived from AMSCs might be responsible for the radioresistance of breast cancer cells.

Conclusions: Our results suggest that AMSCs in the tumor microenvironment may affect the outcome of radiotherapy for breast cancer in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / cytology
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / radiotherapy
  • Cell Line, Tumor
  • Cell Movement / radiation effects
  • Cell Proliferation / physiology*
  • Cell Proliferation / radiation effects
  • Female
  • Histones / metabolism
  • Histones / radiation effects
  • Humans
  • Insulin-Like Growth Factor I / metabolism*
  • MCF-7 Cells
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism*
  • Radiation*
  • Receptor, IGF Type 1
  • Receptors, Somatomedin / metabolism
  • Receptors, Somatomedin / radiation effects
  • Tumor Microenvironment

Substances

  • H2AX protein, human
  • Histones
  • IGF1 protein, human
  • IGF1R protein, human
  • Receptors, Somatomedin
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1